progressive familial intrahepatic cholestasis pfic group familial cholestatic conditions caused defects biliary epithelial transporters clinical presentation usually occurs first childhood progressive cholestasis usually leads failure thrive cirrhosis need liver transplantationcitation needed types progressive familial intrahepatic cholestasis followscitation needed onset disease usually age patients diagnosed pfic even adolescence three entities usually presents earliest patients usually present early childhood cholestasis jaundice failure thrive intense pruritus patients present adolescence linked suicide patients may fat malabsorption leading fat soluble vitamin deficiency complications including caused variety mutations gene coding ptype atpase protein responsible phospholipid translocation across previously identified clinical entities known bylers disease greenlandeskimo familial cholestasis patients may also watery diarrhea addition clinical features due expression intestine mutation leads cholestasis yet well understoodcitation needed caused variety mutations gene codes bile salt export pump bsep retention bile salts within hepatocytes cell type express bsep causes hepatocellular damage cholestasiscitation needed caused variety mutations gene encoding multidrug resistance protein codes floppase responsible phosphatidylcholine translocation defective phosphatidylcholine translocation leads lack phosphatidylcholine bile phosphatidylcholine normally chaperones bile acids preventing damage biliary epithelium free unchaperoned bile acids bile patients deficiency cause cholangitis biochemically note associated markedly elevated ggtcitation needed inheritance pattern three forms pfic defined date autosomal recessivecitation needed liver biopsies typically show evidence cholestasis including bile plugs bile infarcts duct hypoplasia hepatocellular injury zone fibrosis giant cell change features hepatocellular injury pronounced endstage disease forms pfic defined date characterized bridging fibrosis duct proliferation periportal biochemical markers include normal ggt markedly elevated ggt serum bile acid levels grossly elevated serum cholesterol levels typically elevated seen usually cholestasis pathology due transporter opposed anatomical problem biliary cellscitation needed initial treatment supportive use agents treat cholestasis pruritus including followingcitation needed partial external biliary diversion pebd procedure surgical approach diverts bile gallbladder externally ileostomy patients supplemented fatsoluble vitamins occasionally mediumchain triglycerides order improve growth liver synthetic dysfunction significant patients listed transplantation family members tested pfic mutations order determine risk transmissioncitation needed disease typically progressive leading fulminant liver failure death childhood absence liver transplantation hepatocellular carcinoma may develop early age even toddlers affectedcitation needed httpsenwikipediaorgwikiprogressivefamilialintrahepaticcholestasis